Skip Navigation
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Volunteer for Malaria Vaccine Research

About the VRC 312 Clinical Trial

There are no vaccines to prevent malaria. It is a disease that threatens nearly half of the world’s population. The purpose of this research study is to test the safety of an experimental vaccine, called PfSPZ Vaccine. We will also be studying whether or not the vaccine can prevent malaria.

You can read more about the study at ClinicalTrials.gov.

Who can participate in this research?

Healthy adults between 18 and 45 years of age may be eligible to participate in this study.

What does the study involve?

Volunteers are screened with a physical exam, medical history, and blood tests. There are 5 different groups in the study. Follow-up may last between 12 and 52 weeks, depending upon the group.

Where is study enrollment taking place?

The NIH Clinical Center in Bethesda, Maryland. The NIH campus is accessible by car and public transportation.

Will I receive payment?

You will be compensated for your participation in the study.

Who should I contact about this clinical study?

For more information on VRC 312 (ClinicalTrials.gov Identifier: NCT01441167), call toll-free 1-866-833-5433, or email vaccines@nih.gov.

Last Updated March 28, 2012

Last Reviewed March 26, 2012